Unknown OBSERVATIONAL NCT03793231

fungalAi for Fungal Surveillance & Antifungal Stewardship (fungalAi)

Innovative Use of fungalAi for Antifungal Stewardship in Haematology-oncology Patients

Sponsor: Bayside Health

Interventions fungalAi platform technology

Updated 7 times since 2019 Last updated: Oct 22, 2020 Started: Jan 1, 2019 Primary completion: Dec 30, 2020 Completion: Dec 30, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Fungal Infections, this trial is ongoing. The trial is conducted by Bayside Health and has accumulated 7 data snapshots since 2019. Infectious disease trials contribute critical data for public health response and treatment development.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Unknown
Jul 2024 — Sep 2024 [monthly]

Unknown

Status: Unknown Status → Unknown
Nov 2022 — Jul 2024 [monthly]

Unknown Status

Status: Enrolling By Invitation → Unknown Status
Jan 2021 — Nov 2022 [monthly]

Enrolling By Invitation
Nov 2020 — Jan 2021 [monthly]

Enrolling By Invitation

▶ Show 2 earlier versions

Jul 2019 — Nov 2020 [monthly]

Enrolling By Invitation
Feb 2019 — Jul 2019 [monthly]

Enrolling By Invitation

First recorded

Jan 2019

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Bayside Health
Eastern Health
Fremantle Hospital and Health Service
Monash Health
Monash University
SA Health
Singhealth Foundation
Western Sydney Local Health District

Data source: Bayside Health

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Melbourne, Australia